News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,146 Results
Type
Article (89675)
Company Profile (639)
Press Release (807808)
Multimedia
Podcasts (283)
Webinars (44)
Section
Business (267511)
Career Advice (4176)
Deals (40162)
Drug Delivery (246)
Drug Development (92151)
Employer Resources (212)
FDA (18737)
Job Trends (17563)
News (399632)
Policy (40038)
Tag
2025 Best Places to Work (25)
2026 Best Places to Work (39)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (13)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (7)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (10)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (76)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (57000)
ALS (292)
Alzheimer's disease (2149)
Antibody-drug conjugate (ADC) (778)
Approvals (19333)
Artificial intelligence (1147)
ASCO (350)
Autoimmune disease (537)
Automation (84)
Bankruptcy (414)
Belgium (45)
Best Places to Work (12636)
BIO (84)
Biologics (118)
BIOSECURE Act (23)
Biosimilars (308)
BioSpace Insights (271)
Biotechnology (340)
Bispecific (60)
Bladder cancer (253)
Brain cancer (104)
Breast cancer (980)
Cancer (8061)
Cardiovascular disease (684)
Career advice (3638)
Career pathing (65)
CAR-T (465)
CDC (82)
CDMO (236)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1279)
Cervical cancer (67)
Clinical research (81240)
Collaboration (2893)
Commercialization (76)
Company closure (10)
Compensation (1937)
Complete response letters (128)
COVID-19 (3089)
CRISPR (155)
CRO (8)
C-suite (1713)
Cystic fibrosis (182)
Data (11173)
Decentralized trials (4)
Denatured (112)
Depression (230)
Dermatology (207)
Diabetes (855)
Diagnostics (7948)
Digital health (85)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (565)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (388)
Earnings (104810)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (141991)
Executive appointments (1385)
Eye disease (28)
FDA (23866)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2380)
Gene editing (323)
Generative AI (116)
Gene therapy (988)
GLP-1 (1416)
Government (5635)
Grass and pollen (8)
Guidances (446)
Healthcare (21523)
Hematology (236)
HIV (128)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (431)
Immuno-oncology (166)
Indications (298)
Infectious disease (3551)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (389)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2882)
JPM (73)
Kidney cancer (32)
Kidney disease (182)
Labor market (152)
Layoffs (733)
Leadership (70)
Legal (10180)
Licensing (130)
Liver cancer (121)
Longevity (58)
Lung cancer (1110)
Lung diease (27)
Lymphoma (566)
Machine learning (78)
Management (72)
Manufacturing (1660)
Marketing (41)
MASH (260)
Medical affairs (5)
Medical device (15486)
Medtech (15823)
Mergers & acquisitions (23653)
Metabolic disorders (2175)
Middle East (2)
mRNA (344)
Multiple sclerosis (262)
Multispecific (6)
NASH (24)
Netherlands (40)
Neurodegenerative disease (637)
Neuropsychiatric disorders (155)
Neuroscience (4367)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (101)
Obesity (1027)
Opinion (410)
Ovarian cancer (301)
Pain (352)
Pancreatic cancer (459)
Parkinson's disease (495)
Partnered (53)
Patents (815)
Patient advocacy (8)
Patient recruitment (988)
Patient selection (117)
Peanut (81)
People (69164)
Peptides (44)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25054)
Phase 2 (35288)
Phase 3 (26600)
Pipeline (14670)
Policy (435)
Postmarket research (3561)
Preclinical (11210)
Press Release (74)
Prostate cancer (413)
Psychedelics (104)
Radioligand (3)
Radiopharmaceuticals (449)
Rare diseases (1615)
Real estate (7479)
Recruiting (84)
Regenerative medicine (38)
Regulatory (31902)
Reports (104)
Research institute (2823)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (410)
Series B (285)
Service/supplier (17)
Sickle cell disease (152)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4405)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (173)
Switzerland (25)
Tariffs (108)
Tax incentives (2)
The Weekly (168)
Vaccines (1447)
Venture capital (185)
Weight loss (683)
Wet AMD (7)
Women's health (190)
Women in leadership (2)
Worklife (28)
Date
Today (248)
Last 7 days (972)
Last 30 days (4017)
Last 365 days (34095)
2026 (30775)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1310)
Alabama (118)
Alaska (7)
Arizona (493)
Arkansas (17)
Asia (53208)
Australia (9370)
California (17375)
Canada (4780)
China (2069)
Colorado (772)
Connecticut (776)
Delaware (548)
Europe (122863)
Florida (2632)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1502)
India (156)
Indiana (786)
Iowa (37)
Japan (783)
Kansas (159)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2049)
Massachusetts (12572)
Michigan (476)
Minnesota (954)
Mississippi (8)
Missouri (190)
Montana (38)
Nebraska (31)
Nevada (205)
New Hampshire (94)
New Jersey (4601)
New Mexico (38)
New York (4525)
North Carolina (2250)
North Dakota (14)
Northern California (8875)
Ohio (542)
Oklahoma (32)
Oregon (55)
Pennsylvania (3324)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6925)
Tennessee (287)
Texas (2891)
United States (61578)
Utah (527)
Vermont (2)
Virginia (436)
Washington D.C. (89)
Washington State (1387)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
898,146 Results for "apr applied pharma research s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Lilly’s early-stage M&A quest finds $1.5B deal for Calytrix’s blood cancer work
Eli Lilly’s business development team has inked 14 buyouts this year so far, with Calytrix Bio tucking into the pharma’s oncology pipeline.
November 16, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Applied Biologics Announces Research Collaboration with Dartmouth College Focused on Computational Protein Engineering
November 11, 2026
·
3 min read
Podcast
Data leak kickstarts ESMO, BMS reports autoimmune CAR T death, pharma M&A outpaces 2025
Merck stole the show at the European Society for Medical Oncology (ESMO) annual conference, with new data on its Moderna-partnered personalized cancer vaccine leaking prior to the presentation and antibody-drug conjugate sac-TMT making a splash in endometrial cancer; Bristol Myers Squibb revealed the death of a patient with multiple sclerosis in an early-stage trial of zola-cel; and pharma is on track to easily surpass last year’s deal count.
October 28, 2026
·
1 min read
·
Jef Akst
Mergers & acquisitions
Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity
Over the past decade, Eli Lilly has bought out more biotechs than any of the other top 12 pharmas by revenue—with 10 of those acquisitions arriving just this year.
June 10, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Kairos Pharma Presents at United Scientific Group’s 11th International Conference on Cancer Research & Drug Development
November 3, 2026
·
4 min read
Press Releases
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro ™
October 14, 2026
·
1 min read
Legal
‘Pharma bro’ Shkreli runs afoul of court’s lifetime pharma ban
Since his release from prison in 2022, Martin Shkreli has traded stocks and publicly opined on news events, damaging reputations and sinking share prices for small biotechs including Capricor and Cassava, the FTC alleges.
October 14, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Applied Biologics Publishes New Translational Research Demonstrating Ligament Regeneration with XWRAP®-Based Biologic Augmentation
September 30, 2026
·
5 min read
Manufacturing
Sun Pharma stops eye-care drug production at Indian plant amid quality issues
The cessation of manufacturing activities follows a Sun Pharma recall and reports that regulators found fault with the company’s quality system.
November 2, 2026
·
2 min read
·
Nick Paul Taylor
Job Trends
Behind the scenes of 3 Big Pharma layoffs
Three former employees of large pharmas, including Novo and Sanofi, share how they were let go. While they appreciated some aspects of their experiences, such as severance and outplacement resources, they criticized a lack of public transparency, a mishandled notification and puzzling outsourcing.
October 28, 2026
·
5 min read
·
Angela Gabriel
1 of 89,815
Next